Neuropharmacological characterization of the new psychoactive substance methoxetamine
Neuropharmacology September 1, 2017 Laura Hondebrink, E. Kasteel, A. Tukker et al.
&NA; The use of new psychoactive substances (NPS) is steadily increasing. One commonly used NPS is methoxetamine (MXE), a ketamine analogue. Several adverse effects have been reported following MXE exposure, while only limited data are available on its neuropharmacological modes of action. We investigated the effects of MXE and ketamine on several endpoints using multiple in vitro models. These...